Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer …
K Yoshida, T Sugiura, N Takifuji, M Kawahara, K Matsui… - Lung Cancer, 2007 - Elsevier
To evaluate the efficacy and toxicity of three intrapleural therapy regimens consisting of
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer …
K Yoshida, T Sugiura, N Takifuji, M Kawahara, K Matsui… - Lung Cancer, 2007 - infona.pl
To evaluate the efficacy and toxicity of three intrapleural therapy regimens consisting of
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer …
K Yoshida, T Sugiura, N Takifuji, M Kawahara… - Lung …, 2007 - lungcancerjournal.info
To evaluate the efficacy and toxicity of three intrapleural therapy regimens consisting of
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer …
K Yoshida, T Sugiura, N Takifuji… - Lung Cancer …, 2007 - europepmc.org
To evaluate the efficacy and toxicity of three intrapleural therapy regimens consisting of
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
[引用][C] Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung …
K YOSHIDA, T SUGIURA, N SAIJO, N TAKIFUJI… - Lung …, 2007 - pascal-francis.inist.fr
Randomized phase II trial of three intrapleural therapy regimens for the management of
malignant pleural effusion in previously untreated non-small cell lung cancer : JCOG 9515 …
malignant pleural effusion in previously untreated non-small cell lung cancer : JCOG 9515 …
[引用][C] Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung …
K YOSHIDA - Lung Cancer, 2007 - cir.nii.ac.jp
Randomized phase II trial of three intrapleural therapy regimens for the management of
malignant pleural effusion in previously untreated non-small cell lung cancer : JCOG 9515 …
malignant pleural effusion in previously untreated non-small cell lung cancer : JCOG 9515 …
Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer …
K Yoshida, T Sugiura, N Takifuji… - Lung cancer …, 2007 - pubmed.ncbi.nlm.nih.gov
To evaluate the efficacy and toxicity of three intrapleural therapy regimens consisting of
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
bleomycin (BLM), OK-432 (a pulverized product of heat-killed Streptococcus pyogenes) or …
[引用][C] Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non small cell lung …
K YOSHIDA - Lung Cancer, 2007 - cir.nii.ac.jp
Randomized phase II trial of three intrapleural therapy regimens for the management of
malignant pleural effusion in previously untreated non small cell lung cancer : JCOG 9515 …
malignant pleural effusion in previously untreated non small cell lung cancer : JCOG 9515 …